Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas

T. Mimae, K. Tsuta, T. Kondo, H. Nitta, T. M. Grogan, M. Okada, Hisao Asamura, H. Tsuda

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-type 2 (HER2), and c-Met are members of the receptor tyrosine kinases (RTKs). The associations between the RTK status [protein expression and gene copy number (GCN)] and patient characteristics and between the RTK status and prognosis remain undetermined. Materials and methods: The study included 140 patients who underwent surgery for thymic tumors. Protein expression was evaluated by immunohistochemistry (IHC) and GCN was evaluated by bright-field in situ hybridization (BISH). The correlations between the RTK status and clinicopathological findings were examined. Results: IGF-1R protein was frequently detected in thymic carcinoma (83.8%) and EGFR in thymic tumors (91.4%). Thirty-six and 39 tumors were BISH high for IGF-1R and EGFR, respectively: 28 and 25 exhibited high polysomy; 8 and 14 exhibited gene amplification. No tumor was positive for HER2 or c-Met by IHC and BISH. Multivariate analysis revealed that IGF-1R gene amplification (P = 0.027), thymic carcinoma histology, and higher tumor stage were significantly correlated with an adverse prognosis. Conclusions: Thymic epithelial tumors frequently express IGF-1R and/or EGFR proteins. IGF-1R gene amplification is suggested to define an unfavorable subset for thymic epithelial tumors.

Original languageEnglish
Article numbermds147
Pages (from-to)3129-3137
Number of pages9
JournalAnnals of Oncology
Volume23
Issue number12
DOIs
Publication statusPublished - 2012 Dec
Externally publishedYes

Fingerprint

Somatomedin Receptors
Thymoma
Gene Dosage
Receptor Protein-Tyrosine Kinases
Epidermal Growth Factor Receptor
Gene Amplification
Thymus Neoplasms
In Situ Hybridization
Proteins
Immunohistochemistry
Proto-Oncogene Proteins c-met
Neoplasms
Histology
Multivariate Analysis

Keywords

  • Gene copy number
  • Insulin-like-growth factor-1 receptor
  • Thymic carcinoma
  • Thymoma
  • Tyrosine kinase receptors

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Mimae, T., Tsuta, K., Kondo, T., Nitta, H., Grogan, T. M., Okada, M., ... Tsuda, H. (2012). Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. Annals of Oncology, 23(12), 3129-3137. [mds147]. https://doi.org/10.1093/annonc/mds147

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. / Mimae, T.; Tsuta, K.; Kondo, T.; Nitta, H.; Grogan, T. M.; Okada, M.; Asamura, Hisao; Tsuda, H.

In: Annals of Oncology, Vol. 23, No. 12, mds147, 12.2012, p. 3129-3137.

Research output: Contribution to journalArticle

Mimae, T, Tsuta, K, Kondo, T, Nitta, H, Grogan, TM, Okada, M, Asamura, H & Tsuda, H 2012, 'Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas', Annals of Oncology, vol. 23, no. 12, mds147, pp. 3129-3137. https://doi.org/10.1093/annonc/mds147
Mimae, T. ; Tsuta, K. ; Kondo, T. ; Nitta, H. ; Grogan, T. M. ; Okada, M. ; Asamura, Hisao ; Tsuda, H. / Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. In: Annals of Oncology. 2012 ; Vol. 23, No. 12. pp. 3129-3137.
@article{fde2a6aa6bd2484faeeed1aada57bc6b,
title = "Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas",
abstract = "Background: Insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-type 2 (HER2), and c-Met are members of the receptor tyrosine kinases (RTKs). The associations between the RTK status [protein expression and gene copy number (GCN)] and patient characteristics and between the RTK status and prognosis remain undetermined. Materials and methods: The study included 140 patients who underwent surgery for thymic tumors. Protein expression was evaluated by immunohistochemistry (IHC) and GCN was evaluated by bright-field in situ hybridization (BISH). The correlations between the RTK status and clinicopathological findings were examined. Results: IGF-1R protein was frequently detected in thymic carcinoma (83.8{\%}) and EGFR in thymic tumors (91.4{\%}). Thirty-six and 39 tumors were BISH high for IGF-1R and EGFR, respectively: 28 and 25 exhibited high polysomy; 8 and 14 exhibited gene amplification. No tumor was positive for HER2 or c-Met by IHC and BISH. Multivariate analysis revealed that IGF-1R gene amplification (P = 0.027), thymic carcinoma histology, and higher tumor stage were significantly correlated with an adverse prognosis. Conclusions: Thymic epithelial tumors frequently express IGF-1R and/or EGFR proteins. IGF-1R gene amplification is suggested to define an unfavorable subset for thymic epithelial tumors.",
keywords = "Gene copy number, Insulin-like-growth factor-1 receptor, Thymic carcinoma, Thymoma, Tyrosine kinase receptors",
author = "T. Mimae and K. Tsuta and T. Kondo and H. Nitta and Grogan, {T. M.} and M. Okada and Hisao Asamura and H. Tsuda",
year = "2012",
month = "12",
doi = "10.1093/annonc/mds147",
language = "English",
volume = "23",
pages = "3129--3137",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas

AU - Mimae, T.

AU - Tsuta, K.

AU - Kondo, T.

AU - Nitta, H.

AU - Grogan, T. M.

AU - Okada, M.

AU - Asamura, Hisao

AU - Tsuda, H.

PY - 2012/12

Y1 - 2012/12

N2 - Background: Insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-type 2 (HER2), and c-Met are members of the receptor tyrosine kinases (RTKs). The associations between the RTK status [protein expression and gene copy number (GCN)] and patient characteristics and between the RTK status and prognosis remain undetermined. Materials and methods: The study included 140 patients who underwent surgery for thymic tumors. Protein expression was evaluated by immunohistochemistry (IHC) and GCN was evaluated by bright-field in situ hybridization (BISH). The correlations between the RTK status and clinicopathological findings were examined. Results: IGF-1R protein was frequently detected in thymic carcinoma (83.8%) and EGFR in thymic tumors (91.4%). Thirty-six and 39 tumors were BISH high for IGF-1R and EGFR, respectively: 28 and 25 exhibited high polysomy; 8 and 14 exhibited gene amplification. No tumor was positive for HER2 or c-Met by IHC and BISH. Multivariate analysis revealed that IGF-1R gene amplification (P = 0.027), thymic carcinoma histology, and higher tumor stage were significantly correlated with an adverse prognosis. Conclusions: Thymic epithelial tumors frequently express IGF-1R and/or EGFR proteins. IGF-1R gene amplification is suggested to define an unfavorable subset for thymic epithelial tumors.

AB - Background: Insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), human epidermal growth factor receptor-type 2 (HER2), and c-Met are members of the receptor tyrosine kinases (RTKs). The associations between the RTK status [protein expression and gene copy number (GCN)] and patient characteristics and between the RTK status and prognosis remain undetermined. Materials and methods: The study included 140 patients who underwent surgery for thymic tumors. Protein expression was evaluated by immunohistochemistry (IHC) and GCN was evaluated by bright-field in situ hybridization (BISH). The correlations between the RTK status and clinicopathological findings were examined. Results: IGF-1R protein was frequently detected in thymic carcinoma (83.8%) and EGFR in thymic tumors (91.4%). Thirty-six and 39 tumors were BISH high for IGF-1R and EGFR, respectively: 28 and 25 exhibited high polysomy; 8 and 14 exhibited gene amplification. No tumor was positive for HER2 or c-Met by IHC and BISH. Multivariate analysis revealed that IGF-1R gene amplification (P = 0.027), thymic carcinoma histology, and higher tumor stage were significantly correlated with an adverse prognosis. Conclusions: Thymic epithelial tumors frequently express IGF-1R and/or EGFR proteins. IGF-1R gene amplification is suggested to define an unfavorable subset for thymic epithelial tumors.

KW - Gene copy number

KW - Insulin-like-growth factor-1 receptor

KW - Thymic carcinoma

KW - Thymoma

KW - Tyrosine kinase receptors

UR - http://www.scopus.com/inward/record.url?scp=84869849422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869849422&partnerID=8YFLogxK

U2 - 10.1093/annonc/mds147

DO - 10.1093/annonc/mds147

M3 - Article

C2 - 22700994

AN - SCOPUS:84869849422

VL - 23

SP - 3129

EP - 3137

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

M1 - mds147

ER -